Brief: Abionyx Pharma End-March Gross Cash Position At EUR 7.3 Mln

Abionyx Pharma SA

06/05/2021 18:16

May 6 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * ABIONYX PHARMA: FINANCIAL HIGHLIGHTS AND BUSINESS REVIEW
FOR THE
FIRST QUARTER OF 2021
    * GROSS CASH POSITION OF EUR 7.3 MILLION AS OF MARCH 31,
2021
    * FOLLOWING POSITIVE RESULTS IN TREATMENT OF ULTRA-RARE
RENAL
DISEASE IN PATIENT IN FRANCE, CO RECORDED FIRST SALES OF EUR
26,650 EXCLUDING. VAT FOR PERIOD

Source text for Eikon:  ID:nBw5W9DzKa 
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))